SUV420H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.25099999973111E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.157900E-04 |
Normal-vs-Stage2 |
4.784500E-03 |
Normal-vs-Stage3 |
5.97170002336611E-09 |
Normal-vs-Stage4 |
1.07580000463514E-08 |
Stage1-vs-Stage2 |
3.522800E-01 |
Stage1-vs-Stage3 |
9.193400E-04 |
Stage1-vs-Stage4 |
5.822500E-04 |
Stage2-vs-Stage3 |
2.442400E-01 |
Stage2-vs-Stage4 |
1.331420E-01 |
Stage3-vs-Stage4 |
5.393600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.80970000043901E-07 |
Normal-vs-AfricanAmerican |
7.351200E-04 |
Normal-vs-Asian |
1.348190E-01 |
Caucasian-vs-AfricanAmerican |
8.506800E-01 |
Caucasian-vs-Asian |
7.537000E-01 |
AfricanAmerican-vs-Asian |
7.206000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.54010000097804E-08 |
Normal-vs-Female |
2.139700E-03 |
Male-vs-Female |
1.664740E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.636800E-04 |
Normal-vs-Age(41-60Yrs) |
5.72599999999479E-05 |
Normal-vs-Age(61-80Yrs) |
1.21419999998817E-06 |
Normal-vs-Age(81-100Yrs) |
3.98700000000529E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.428400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.970400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.503200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.113800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.114970E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.341600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.917800E-01 |
Normal-vs-Grade 2 |
5.883000E-03 |
Normal-vs-Grade 3 |
2.4705000267744E-09 |
Normal-vs-Grade 4 |
3.36775052289795E-12 |
Grade 1-vs-Grade 2 |
1.764840E-01 |
Grade 1-vs-Grade 3 |
1.683570E-03 |
Grade 1-vs-Grade 4 |
3.59079999999734E-05 |
Grade 2-vs-Grade 3 |
3.98850000000728E-05 |
Grade 2-vs-Grade 4 |
1.30749999716073E-08 |
Grade 3-vs-Grade 4 |
1.172180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.008400E-02 |
Normal-vs-ccB subtype |
1.67890001900872E-09 |
ccA subtype-vs-ccB subtype |
4.74469999955929E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.40740000001516E-06 |
Normal-vs-N1 |
1.46649999999138E-06 |
N0-vs-N1 |
2.641800E-02 |
|
|